Belgium-based brain imaging technology developer Icometrix has secured $18m in a funding round co-led by Optum Ventures, healthcare and medical services provider Optum’s strategic investment vehicle.
The round was co-led by Forestay Capital, a subsidiary of investment group Waypoint Capital, and venture capital fund manager Capricorn Venture Partners.
Founded in 2011, Icometrix has created a software platform called Icobrain that supports the evaluation of brain scans to diagnose neurological disorders including multiple sclerosis (MS), Alzheimer’s disease and traumatic brain injury.
The software uses artificial intelligence technology to automatically segment visual data and compare the patient to healthy subjects in a given demographic.
Icometrix, which was spun out of Katholieke Universiteit (KU) Leuven and University of Antwerp, currently markets three products based on the approach, catered to MS, dementia and traumatic brain injuries respectively.
The company received more than $2.2m in a 2016 round featuring KU Leuven, University of Antwerp and Antwerp University Hospital, as well as Capricorn’s ICT Arkiv fund, Annie Vereecken on behalf of investment vehicle Biover II, and angel investors including Herman Verrelst.
The original version of this article appeared on our sister site, Global University Venturing.